Trial Profile
Study of OTSA101 in patients with Synovial Sarcomas
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 28 Mar 2016
Price :
$35
*
At a glance
- Drugs OTSA 101-Y 90 (Primary)
- Indications Synovial sarcoma
- Focus Adverse reactions
- Sponsors OncoTherapy Science
- 28 Mar 2016 New trial record
- 23 Mar 2016 According to OncoTherapy media release, company is planning to initiate this trial for the new drug application in Japan, USA and EU.